(Updated: 2021/11/19)

About the journal

Basic information

 

The Brazilian Journal of Medical and Biological Research had the PRINT ISSN  ISSN-0100-879X from 1981 to 1997.

After 1997, the ISSN of the Brazilian Journal of Medical and Biological Research was modified to ISSN-1414-431X because it became an Electronic Journal.

The Journal is published only in electronic version and is an open-access, anonymous peer-reviewed journal published by the Associação Brasileira de Divulgação Científica (ABDC), which is a Federation of Brazilian Scientific Societies (SBBf, SBFTE, SBFis, SBI, SBIC, SBNeC, SBBq, SBBC).  The ABDC is a nonprofit organization of scientists committed to making the world's scientific and medical literature a public resource.

The Brazilian Journal of Medical and Biological Research is edited at the Campus of Ribeirão Preto, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil. 

The publication of the Journal is partially financed by CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico), MCT (Ministério da Ciência e Tecnologia), CAPES (Coordenação de Pessoal de Nivel Superior), ME (Ministério de Educação), and FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo).

The articles of the Journal are published online, continuously. All research articles published by the Brazilian Journal of Medical and Biological Research since 1997 are available at www.scielo.br/bjmbr and www.bjournal.org. The Brazilian Journal of Medical and Biological Research articles are tracked by PubMed, PubMed Central, ISI Knowledge, and Scopus.

The Journal is indexed by all major indexing services, including Web of Knowledge and PubMed. The Journal applies the Creative Commons Attribution License (CC BY) to all works published.

Under the CC BY, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles in the Brazilian Journal of Medical and Biological Research, as long as the original authors and source are cited. No permission is required from the authors or the publishers.

 

Scope and policy

 

The purpose of the Journal is to publish the results of original experimental research that contribute significantly to knowledge in the medical and biological sciences. Major criteria for acceptance are scientific quality, originality, and conciseness. Preference will be given to manuscripts that develop new concepts or experimental approaches and are not merely repositories of data. Papers that report negative results require special justification for publication. Methodological papers shall be considered for publication provided they describe new principles or a significant improvement of an existing method.

Submission of a manuscript to the Journal implies that the data have not been published previously and will not be submitted for publication elsewhere while the manuscript is under review. The following represent “prior publication”: any printed material in excess of 500 words describing results or methods of a submitted/in press manuscript; published tables or illustrations that duplicate the content of a manuscript; electronic manuscripts or posters available via the Internet.

 

 

Papers not be accepted for publication

 
  • Studies on people not approved by an accredited Ethics Committee or without written informed consent from the subject or legal guardian.
  • Studies on animals not approved by an accredited Ethics and Animal Care Committee.
  • Manuscripts that report preliminary results or only confirm previously reported results.
  • Manuscripts that describe the pharmacokinetics bioavailability and toxicity of drugs in people or animals.
  • Manuscripts that deal with transcultural adaptation and validation of instruments of measurements.
  • Manuscripts that translate a text published in another language and validate it on local patients.
  • Manuscripts that use questionnaires translated from the language of another country and their validation in local patients.
  • Manuscripts that present only in silico research.
  • Manuscripts from the area of veterinary medicine.
  • Manuscripts that report toxicological studies.
  • Manuscripts containing purely descriptive observations.
  • Manuscripts reporting new techniques will be published only when adequately validated and judged by the Editors to represent a significant advance.
  • miRNA-based studies will receive low priority from the Journal except when the Editors consider the research provides an outstanding contribution to current literature.
 

 

Manuscripts that report biological activity of natural products

 

The Journal will consider papers for publication that describe the activity of substances of biological origin only if they satisfy all of the following criteria:

  • Papers should describe the separation of the crude material into fractions (not necessarily into homogeneous materials) with the fractions containing biological activity identified clearly in the separation scheme. Phytochemical studies should be accompanied by biological tests. A survey of pharmacological activity of plant extracts or teas will not be considered for publication.o    In addition to the demonstration of activity in one or more biological system, experiments must be performed attempting to provide information concerning the mechanism(s) of action of the substance(s) being tested.
  • Sufficient experimental information must be provided to permit repetition of the preparation of fractions and the bioassay used.
  • Sources should be identified completely, and, if plant material, a specimen should be classified by an expert and deposited in a local botanical garden, university or research institute. The name and institution of the person who classified the plant and the number of the voucher under which it was deposited should be provided in the Material and Methods section.

Systematic Reviews and Meta-analyses

Guidance for reporting of systematic reviews and meta-analyses in the Brazilian Journal of Medical and Biological Research.

Search strategy and selection criteria

  • Start with a study descriptor. Is this a systematic review only (ie, an assessment of heterogenous trials with no summary estimate) or does it also include a meta-analysis (with an overall summary estimate from available data)?
  • What were the criteria for study inclusion? List study dates, language requirements, populations assessed, and study design (eg, only randomized controlled trials or only observational studies).
  • State any study exclusion criteria and reasons.
  • Describe the data sources assessed. List databases searched (including website) and exact cutoff dates. Provide search terms used for at least one database such that the search can be repeated.
  • How thorough was the search (eg, study authors contacted, grey literature sources assessed, and articles translated)?
  • Did you search trial registries and seek data from any unpublished studies identified?
  • What level of data was sought (individual patient-level data vs summary estimates)?
  • Who did the searches and data extraction, and how were conflicts over inclusion resolved? Describe criteria for inclusion in the systematic review and also for inclusion in the meta-analysis (if different).
  • Provide a link to the study protocol if available online. State statistics package and version number used for analyses.
  • List study registration number and name of registry, if available.

Reports must conform to PRISMA 2009 guidelines

Provide the study’s registration number (eg, with PROSPERO)

 

 

Information services

 

The journal is covered by:

  • Pubmed
  • PubMed Central
  • MEDLINE, Index Medicus
  • Science Citation Index Expanded (Web of Science)
  • Science Citation Index
  • Current Contents Life Sciences
 

 

Editorial board

Editors

 
  • Dr. Eduardo Magalhães Rego – http://lattes.cnpq.br/1543544998729361

    Graduou-se em Medicina pela Faculdade de Medicina de Ribeirão Preto – USP (FMRP-USP) em 1988 e obteve o Título de Doutor em Medicina (Clínica Médica) pela Universidade de São Paulo em 1997. Foi Post-Doctoral Fellow no Memorial Sloan Kettering Cancer Center de Nova York (1998-2001). Ao retornar ao Brasil, obteve o Título de Livre-Docente pela USP em 2002 e foi Professor Titular da FMRP-USP de 2010 a 2018. Atualmente é Professor Titular da Faculdade de Medicina da USP (FM-USP) e coordenador do Serviço de Leucemias Agudas do Instituto do Câncer de São Paulo (ICESP). É o Coordenador dos  Serviços de Hematologia da Rede D’Or (Oncologia D’Or).
     
  • Dra. Luisa Lina Villa – http://lattes.cnpq.br/8379358682656422

    Possui graduação em Ciências Biológicas pela Universidade de São Paulo -USP (1972) e doutorado em Ciências (Bioquímica) pelo Instituto de Química da USP (1978). Foi pesquisadora da filial de São Paulo do Instituto Ludwig de Pesquisa sobre o Câncer de 1983 a 2011, tendo sido sua diretora no período de 2006 a 2010. Desde maio de 2011 é docente do Depto. de Radiologia e Oncologia da Faculdade de Medicina da USP, tendo obtido o título de Professor Livre Docente em 2013. chefe do laboratório de Inovação em Câncer do Centro de Investigação Translacional em Oncologia do ICESP. É membro titular da Academia Brasileira de Ciências e Comendadora da Ordem Nacional do Mérito Científico. Em 2010, recebeu o prêmio SCOPUS Brasil, oferecido pela Elsevier pela sua contribuição científica. Em 2018 recebeu menção honrosa no Prêmio Peter Muranyi e recebeu o prêmio de Biologia da Third World Academy of Sciences (TWAS), em Trieste, Italia
  • Dr. João Pereira Leite – http://lattes.cnpq.br/5191541542901913

    Graduado em medicina pela Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP). (1984), obteve o mestrado em Neurologia pela Escola Paulista de Medicina – UNIFESP (1990), o doutorado em Medicina (Neurologia) pela Universidade Federal de São Paulo (1992), e a livre-docência em Neurologia pela FMRP-USP (2001). Atualmente é Professor Titular, Chefe do Departamento de Neurociências e Ciências do Comportamento e Coordenador do Programa de Pós-Graduação em Neurologia da FMRP-USP (Nota 7 CAPES por 3 avaliações consecutivas). Foi presidente da Comissão de Pesquisa da FMRP-USP de 2006-2009. Foi Membro Titular do Conselho Técnico Científico do Ensino Superior (2007 – 2014) e Coordenador da Área de Medicina II por dois triênios consecutivos (triênios 2007-2009 e 2010-2012) da CAPES.
  • Dr. Roberto César Pereira Lima Júnior – http://lattes.cnpq.br/8104904120076956

    Roberto César Pereira Lima Júnior é graduado em Farmácia (2003), Mestre (2005) e Doutor (2008) em Farmacologia pela Universidade Federal do Ceará e pós-doutor pela Università degli Studi di Torino (Itália). Atualmente, é Professor Associado I de Farmacologia da Faculdade de Medicina da Universidade Federal do Ceará, pesquisador de nível 2 do CNPq, membro afiliado da Academia Brasileira de Ciências e coordenador do Laboratório de Farmacologia da Inflamação e do Câncer, Faculdade de Medicina (UFC, Brasil). Supervisiona estudantes de mestrado e doutorado no Programa de Pós-Graduação em Ciências Farmacêuticas do Departamento de Farmácia (UFC), no Programa de Pós-Graduação em Patologia do Departamento de Patologia e Medicina Legal (UFC) e no Programa de Pós-Graduação em Farmacologia do Departamento de Fisiologia e Farmacologia (UFC). Atuou como vice-coordenador do Programa de Pós-graduação em Ciências Farmacêuticas em 2017. O foco da pesquisa desenvolvida em seu laboratório envolve a patogênese das toxicidades relacionadas à quimioterapia do câncer, na qual já publicou mais de 70 artigos científicos. Uma das últimas contribuições nesta área diz respeito à descrição da cascata inflamatória envolvida na mucosite intestinal induzida pelo irinotecano e ao papel de células T regulatórias (Tregs), do óxido nítrico, interleucina-18, interleucina-33 e receptores Toll-like em tal doença.
  • Dr. Itamar de Souza Santos – http://lattes.cnpq.br/6989790016592322

    Graduado em Medicina pela Universidade de São Paulo (2000), cursou três anos de Residência Médica em Clínica Médica no Hospital das Clínicas da Faculdade de Medicina da USP (2004) e doutorado em Ciências Médicas pela Universidade de São Paulo (2009). É Professor Livre-Docente, titulado pela Faculdade de Medicina da Universidade de São Paulo (2016). Bacharel em Matemática Aplicada e Computacional, com Habilitação em Saúde Pública, pela Universidade de São Paulo (2017). Atualmente é Professor Associado (MS-5) do Departamento de Clínica Médica da Faculdade de Medicina da Universidade de São Paulo. É orientador pleno, nível doutorado, do Programa de Pós-Graduação em Ciências Médicas da Universidade de São Paulo (CAPES 6). Sua linha de pesquisa principal é em epidemiologia clínica.
  • Dra. Claudia Kimie Suemoto – http://lattes.cnpq.br/5056497474649400

    Claudia Suemoto é médica graduada pela Faculdade de Medicina da Universidade de São Paulo (FMUSP), com residência em Clínica Médica e Geriatria pela mesma instituição. Tem doutorado em Ciências, no qual pesquisou a associação entre fatores de risco cardiovascular e demência. Fez mestrado em Epidemiologia e pós-doutorado pela Harvard School of Public Health. Claudia é professora doutora da Disciplina de Geriatria da FMUSP. É pesquisadora do Biobanco para Estudos em Envelhecimento da FMUSP e do Estudo Longitudinal da Saúde do Adulto (ELSA-Brasil). Sua pesquisa tem como principais focos o envelhecimento cerebral normal, as demências e suas associações com doenças cardiovasculares. Em 2016, fui uma das laureadas com o prêmio “Para Mulheres na Ciência” promovido pela L’Oreal, UNESCO e Academia Brasileira de Ciências. Claudia é editora associada da Journal of Alzheimer’s Disease, PLOS One e do Brazilian Journal of Medical and Biological Research.
  • Dr. João Santana da Silva – http://lattes.cnpq.br/1551316349134426

    Graduado em em Ciências Biológicas pela Universidade de São Paulo/USP (1976), mestrado (1979) e doutorado (1983) em Bioquímica pela USP e Pós doutorado nos Estados Unidos na Seattle Biomedical Research Institute (1989 a 1991). Professor Sênior da Faculdade de Medicina de Ribeirão Preto – USP, atualmente Especialista da Fundação Oswaldo Cruz (Fiocruz), Pesquisador 1A do CNPq, membro da Academia Brasileira de Ciências e do corpo editorial do Brazilian Journal of Medical and Biological Research, BioMed Research International e Frontiers in Microbiology. Foi presidente da Sociedade Brasileira de Imunologia, coordenador da área de Ciências Biológicas III da CAPES, coordenador do Programa de Imunologia Básica e Aplicada da Faculdade de Medicina de Ribeirão Preto, Presidente da Comissão de Pós-Graduação da Faculdada de Medicina de Ribeirão Preto, Presidente da Fundação Instituto Polo Avançado em Saúde e ganhador do Prêmio Capes-Elsevier em 2015. A atuação principal é na linha de pesquisa sobre Regulação da Resposta Imune e imunoparasitologia.
 

 

Sections editors

 

Biochemistry and Molecular Biology

Biophysics

Biological Pathogenics Agents

Cell Biology 

Clinical Investigation

Immunology

Neurosciences and Behavior

Pharmacology

Physiology

Editorial board

 
  • Ana Lúcia Marques Ventura
    Federal Fluminense University, UFF, Niterói, RJ, Brazil
     
  • Marcelo de Franco
    Butantan Institute, São Paulo, SP, Brazil
     
  • Alicia Juliana Kowaltowski
    University of São Paulo, São Paulo, SP, Brazil
     
  • Carlos Alexandre Netto
    Federal University of Rio Grande do Sul, UFRGS, Porto Alegre, RS, Brazil
     
  • Cristoforo Scavone
    University of São Paulo, USP, São Paulo, SP, Brazil
     
  • Emer Suavinho Ferro
    University of São Paulo, USP, São Paulo, SP, Brazil
     
  • Esmail Zanjani
    University of Nevada, Reno, Nevada, EUA
     
  • Francisco Barrantes
    National University del Sur, Bahia Blanca, Argentina
     
  • Francisco Tadeu Rantim
    Federal University of São Carlos, UFSCAR, São Carlos, SP, Brazil
     
  • Geoffrey Pilkington
    University of Portsmouth, Portsmouth, UK
     
  • Gilberto Xavier
    University of São Paulo, USP, São Paulo, SP, Brazil
     
  • Giles Alexander Rae
    Federal University of Santa Catarina, UFSC, Florianópolis, SC, Brazil
     
  • Telma M. Tenório Zorn
    University of São Paulo, São Paulo, SP, Brazil
     
  • Marimélia Porcionatto
    Federal University of São Paulo, São Paulo, SP, Brazil
     
  • Hervé Chneiweiss
    Plasticité Gliale, Collège de France, Paris, France
     
  • Jan Nilsson
    Malmö University Hospital, Malmö, Sweden
     
  • Pietro Ciancaglini
    School of Philosophy Science and Literature of Ribeirão Preto, Ribeirão Preto, SP, Brazil
     
  • Joaquim Procópio de Araujo Filho
    University of São Paulo, USP, São Paulo, SP, Brazil
     
  • Cristovam Wanderley Picanço Diniz
    Federal University of Pará, Belém, PA, Brazil
     
  • Carla Dalmaz
    Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
     
  • John Wallace
    University of Calgary, Calgary, Canada
     
  • José Roberto Meyer Fernandes
    Federal University of Rio de Janeiro, URFJ, Rio de Janeiro, RJ, Brazil
     
  • Joyce Annichino-Bizzacchi
    State University of Campinas, Campinas, SP, Brazil
     
  • Luciana V. Rossoni
    University of São Paulo, USP, São Paulo, SP, Brazil
     
  • José Henrique Leal Cardoso
    State University of Ceará, Fortalexa, CE, Brazil
     
  • José Carlos Farias Alves Filhos
    University of São Paulo, USP, São Paulo, SP, Brazil
     
  • Ana Paula Canedo Valente
    Federal University of Rio de Janeiro, UFRJ, Rio de Janeiro, RJ, Brazil
     
  • Daniel Diniz de Carvalho
    Ontario Cancer Institute, Toronto, Canada
     
  • Estela Maris Andrade Forell Bevilacqua
    University of São Paulo, São Paulo, SP, Brazil
     
  • Ohara Augusto
    University of São Paulo, USP, São Paulo, SP, Brazil
     
  • Christopher Kushmerick
    Federal University of Minas Gerais, UFMG, Belo Horizonte, MG, Brazil
     
  • Ernesto Raúl Caffarena
    Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro, RJ, Brazil
     
  • Peter Stanfield
    University of Warwick, Warwick, UK
     
  • Luiz Eurico Nasciutti
    Federal University of Rio de Janeiro, UFRJ, Rio de Janeiro, RJ, Brazil
     
  • Rafael Radi
    Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
     
  • Raul Maranhão
    University of São Paulo, FMUSP, São Paulo, SP, Brazil
     
  • Amélia Maria Ribeiro de Jesus
    Federal University of Sergipe, Aracaju, SE, Brazil
     
  • Rita C. Tostes
    University of São Paulo, USP, São Paulo, SP, Brazil
     
  • Salvador Moncada
    The Wolfson Institute for Biomedical Research, University College London, London, England
     
  • Eneida de Paula
    University of Campinas, Campinas, SP, Brazil
     
  • Sara O. Saad
    State University of Campinas, UNICAMP, Campinas, SP, Brazil
     
  • Sergio Aguiar de Lira
    Mount Sinai School of Medicine, New York, EUA
     
  • Sérgio Paulo Bydlowski
    Fundação Pró-Sangue Hemocentro de São Paulo, São Paulo, SP, Brazil
     
  • Thiago dos Santos Moreira
    University of São Paulo, USP, São Paulo, SP, Brazil
     
  • Vagner Roberto Antunes
    University of São Paulo, USP, São Paulo, SP, Brazil
     
  • Cristina Beatriz Cazabuena Bonorino
    Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, RS, Brazil
 

 

Eletronic publication

 

 

 

Instructions to authors

 

 

2020 Impact Factor 2.590
Qualis 2020 – A4
Average time from submission until Acceptance: 3 months and until Publication: 3
months

 

 

Preparation of research manuscripts

 

The Brazilian Journal of Medical and Biological Research publishes original research articles of outstanding scientific significance. Manuscripts must be submitted in English. We will consider manuscripts of any length; we encourage the submission of both substantial full-length bodies of work and shorter manuscripts that report novel findings that might be based on a limited number of experiments. The key criteria are that the research clearly demonstrates its novelty, its importance to a particular field as well as its interest to those outside that discipline, and conclusions that are justified by the data.

Authorship requirements

Only those persons who contributed directly to the intellectual content of the paper should be listed as authors. Authors should meet all of the following criteria, thereby allowing persons named as authors to take public responsibility for the content of the paper.

  • Conceived, planned and carried out the experiments that led to the paper or interpreted the data it presents, or both.
  • Wrote the paper, or reviewed successive versions.
  • Approved the final version.
    Holding positions of administrative leadership, contributing patients, and collecting and assembling data, however important to the research, are not by themselves criteria for authorship. Other persons who have made substantial, direct contributions to the work but cannot be considered authors should be cited in the Acknowledgment section, with their permission, and a description of their specific contributions to the research should be given.

Author Identification – ORCID

BJMBR and Scielo endorse ORCID and requires that all authors provide an ORCID iD when submitting a manuscript. We encourage coauthors to register and use their ORCID as well. 
We publish all the author’s ORCID iD if the manuscript is accepted. We participate in the auto-update feature implemented by Crossref such that when a paper is published, the authors’ ORCIDs are deposited and subsequently used to update each author’s ORCID record. 

Document signed by ALL authors 

On submission, you must attach a document* signed by ALL authors of the manuscript informing that he/she:
i) participated in the research that led to the manuscript;
ii) read and approved the text, tables, and figures submitted;
iii) verified that the authors’ names, institutions, ORCIDs, and emails are correct.

The manuscript CANNOT be submitted without this document as a pdf file.

*Please upload the document, where indicated, concerning participation in the research, approval of the manuscript submitted, and verification of names, institutions, ORCIDs, and emails signed by EACH author of the manuscript, not by only one author signing for all authors. Signatures must be hand-written by each author. If necessary, individual documents from each author can be uploaded. We do NOT accept computer-generated signatures. There is no special form to be filled out. The document(s) can be a scanned file, photograph, PDF, Word document, or image.

The manuscript CANNOT be submitted without this document as a pdf file.

Resubmissions 

Revised manuscripts must be accompanied by a file that includes a detailed point-by-point listing as to how each of the reviewers’ comments has been addressed and describes any other changes made to the manuscript. Authors are invited to upload a revised version of the manuscript in which all new text modifications made should be in black letter highlighted in yellow. This highlighted yellow text to indicate changes will facilitate evaluation of the revisions by the editors and reviewers.

Plagiarism 

BJMBR uses COPE guidelines (powered by iThenticate) to screen submitted content for originality. If plagiarism is detected during the peer review process, the manuscript may be rejected. If plagiarism is detected after publication, we may issue a retraction of the paper, as appropriate.
We expect that editors and reviewers will be vigilant in their evaluation of BJMBR submissions and will notify the journal about any plagiarism identified.

Publication Charges 

Publication charges (also referred to as “Article Processing Charges” or APCs) help BJMBR recover the costs of publication—including peer review management, journal production, and online hosting and archiving. BJMBR publishes all content Open Access and makes the content freely available online for researchers and readers to read, distribute, and reuse.
The authors are responsible for “publication charges” of all accepted papers. Publication charges will be billed to the Corresponding Author when the paper is accepted. The charge is R$3.300,00/paper for Brazilian authors and US$1,600.00/paper for authors outside Brazil and is independent of the length of the paper. The Journal does not provide reprints to corresponding authors. There is no charge for figures in color.

Please contact Reinaldo de Souza (reinaldo.souza@bjournal.com.br) if you have any questions.

Cover Letter

It is important that you include a cover letter with your manuscript. Take the time to consider why this manuscript is suitable for publication in the Brazilian Journal of Medical and Biological Research. Why will your paper inspire the other members of your field, and how will it drive research forward? Please explain this in your cover letter.

The cover letter should also contain the following information:

  • Title of article.
  • Name(s) of all author(s).
  • Name, complete mailing address, including zip code, telephone number, fax number and e-mail of author to whom correspondence should be sent.
  • If a version of the manuscript has been previously submitted for publication to another journal, include comments from the peer reviewers and indicate how the authors have responded to these comments.
  • Papers in the area of Clinical Investigation should include a statement indicating that the protocol has been approved by the Hospital Ethics Committee (Hospital with which at least one of the authors is associated) and that written informed consent was obtained from all participants. This information must also be cited in the Material and Methods section of the manuscript.

Text format

  • The text of a manuscript can only be accepted as a Microsoft Word file created with MS Word as a "doc", "docx" or "rtf" document.
  • Each page should contain the page number in the upper right-hand corner starting with the title page as page 1.
  • Report all measurements in Système International, SI and standard units where applicable (see below).
  • Do not use abbreviations in the title and limit their use in the abstract and text.
  • The length of the manuscript and the number of tables and figures must be kept to a minimum.
  • Ensure that all references are cited in the text.
  • Generic names must be used for all drugs. Instruments may be referred to by proprietary name; the name and country or electronic address of the manufacturer should be given in parentheses in the text.

Guidance on grammar, punctuation, and scientific writing can be found in the following sources:

  • Scientific Style and Format: The CSE Manual for Authors, Editors, and Publishers. 8th edn. Rockefeller University Press, Reston, 2006. http://www.scientificstyleandformat.org/Home.html
  • Medical Style and Format. Huth EJ (Editor). ISI Press, Philadelphia, 1987, Marketed by Williams & Wilkins, Baltimore, MD.
  • Writing scientific articles like a native English speaker: top ten tips for Portuguese speakers. Clinics (Sao Paulo). Mar 2014; 69(3): 153-157. doi: 10.6061/clinics/2014(03)01. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935133/

The Brazilian Journal of Medical and Biological Research follows the reference format of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, which can be found on the website of the National Library of Medicine.

The writing style should be concise and accessible. Editors will make suggestions for how to achieve this, as well as suggestions for cuts or additions that could be made to the article to strengthen the argument. Our aim is to make the editorial process rigorous and consistent, but not intrusive or overbearing. Authors are encouraged to use their own voice and to decide how best to present their ideas, results, and conclusions.

Although we encourage submissions from around the globe, we require that manuscripts be submitted in American English. As a step towards overcoming language barriers, we encourage authors to seek the assistance of professional services available on the homepage of the journal/Service and Information.

Footnotes

Text footnotes, if unavoidable, should be numbered consecutively in superscript in the manuscript and written on a separate page following the abstract.

Abbreviations

Abbreviations should be kept to a minimum. Define all abbreviations upon first use in the abstract and the text. Non-standard abbreviations should not be used unless they appear at least three times in the text.

  • Explain all abbreviations in the abstract, text, figure and table legends when they first appear. Keep the number of abbreviations to a minimum.
  • Do not explain abbreviations for units of measurement [3 mL, not 3 milliliters (mL)] or standard scientific symbols [Na, not sodium (Na)].
  • Abbreviate long names of chemical substances and terms for therapeutic combinations. Abbreviate names of tests and procedures that are better known by their abbreviations than by the full name (VDRL test, SMA-12).
  • Use abbreviations in figures and tables to save space, but they must be defined in the legend.
  • If your manuscript cites µm/mLµg/mL, or mg/mL, the Greek letter for micro (µ) must be used and the letter “L” must be in upper-case type in the text and figures.
  • All details of centrifugation including g units (not rpm), time, and temperature (oC) must be cited in the Material and Methods section.

Nomenclature

The use of standardized nomenclature in all fields of science and medicine is an essential step toward the integration and linking of scientific information reported in published literature. We will enforce the use of correct and established nomenclature wherever possible: We strongly encourage the use of SI units.

  • s for second
  • min for minute
  • h for hour
  • L for liter
  • m for meter
  • kDa for mass in kilodaltons
  • 5 mM rather than 5 x 10-3 M or 0.005 M

Species names (e.g., Homo sapiens), genes, mutations, genotypes, and alleles should be italicized. Use the recommended name by consulting the appropriate genetic nomenclature database, e.g., HUGO for human genes. It is sometimes advisable to indicate the synonyms for the gene the first time it appears in the text.

The Recommended International Non-Proprietary Name (rINN) of drugs should be provided.

 

 

Manuscript categories

 

Research Articles

Full length Paper should clearly state its objective or hypothesis; the experimental design and methods used; the essential features of any interventions; the main outcome measures; the main results of the study; and a discussion placing the results in the context of published literature.

Short Communication is a report on a single subject, which should be concise but definitive. The scope of this section is intended to be wide and to encompass methodology and experimental data on subjects of interest to the readers of the Journal

Concepts and Comments should provides a platform for readers to present ideas, theories and views.

Case Report should have at least one of the following characteristics to be published in the Journal: 

  • special interest to the clinical research community;
  • a rare case that is particularly useful to demonstrate a mechanism or a difficulty in diagnosis;
  • new diagnostic method;
  • new or modified treatment;
  • a text that demonstrates relevant findings and is well documented and without ambiguity.

Systematic Reviews and Meta-analyses

Guidance for reporting of systematic reviews and meta-analyses in the Brazilian Journal of Medical and Biological Research.

Search strategy and selection criteria

  • The journal requires the registration of clinical trials and systematic review protocols in an adequate primary register platform (e.g., WHO ICTRP, ClinicalTrials.gov, PROSPERO). All information including the registration number must be cited in the Material and Methods section. Systematic reviews will be published as a systematic review, not as a Research Article.
  • Start with a study descriptor. Is this a systematic review only (ie, an assessment of heterogenous trials with no summary estimate) or does it also include a meta-analysis (with an overall summary estimate from available data)?
  • What were the criteria for study inclusion? List study dates, language requirements, populations assessed, and study design (eg, only randomized controlled trials or only observational studies).
  • State any study exclusion criteria and reasons.
  • Describe the data sources assessed. List databases searched and exact date cutoffs. Provide search terms used for at least one database such that the search could be repeated.
  • How thorough was the search (eg, study authors contacted, grey literature sources assessed, and articles translated)?
  • Did you search trial registries and seek data from any unpublished studies identified?
  • What level of data was sought (individual patient-level data vs summary estimates)?
  • Who did the searches and data extraction, and how were conflicts over inclusion resolved? Describe criteria for inclusion in the systematic review and also for inclusion in the meta-analysis (if different).
  • Provide a link to the study protocol if available online. State statistics package and version number used for analyses.
  • List study registration number and name of registry, if available.

Authors should check reporting requirements pointed by the Equator Network according to the type of their article. Specifically, clinical trials and systematic reviews should be accompanied by the study´s registration platform and number (eg, with PROSPERO).

Review Article

Should provide a synthetic and critical analysis of a relevant area and should not be merely a chronological description of the literature. The most important characteristics of Review articles are that they should be critical, synthetic and written by persons who have made significant contributions to the specific research area. The review can be broad or focused, as in a mini-review.  We want to protect the Journal from “reports” of the type that are found in the introduction to every dissertation or thesis.

Review article are submitted to the normal peer review process.

  1. the number of articles published by the author in the area;
  2. the significance of the author’s contribution to the advancement of knowledge in the area;
  3. the quality of the review;
  4. the general interest of the Journal in the publication of such a review.

Overview 

Should not contain unpublished data. It presents the point of view of the author(s) in a less rigorous form than in a regular review or minireview and is of interest to the general reader.

All papers should contain:

  • Abstract of no more than 250 words,
  • key words:  no more than 6,
  • running title to be used as a page heading, which should not exceed 60 letters and spaces,
  • text: when appropriated should be divided into separate sections (Introduction, Material and Methods, Results, Discussion), without a separate section for conclusions.

References
Full Paper and Concepts and Comments should contain no more than 40 references.
Short Communication and Case report should contain no more than 20 references and three illustrations (figures and/or tables). 
Review Article and Overview should contain no more than 90 references.
Figures and Tables (see instructions)

Papers not be accepted for publication 

  • Studies on people not approved by an accredited Ethics Committee or without written informed consent from the subject or legal guardian.
  • Studies on animals not approved by an accredited Ethics and Animal Care Committee.
  • Manuscripts that report preliminary results or only confirm previously reported results.
  • Manuscripts that describe the pharmacokinetics bioavailability and toxicity of drugs in people or animals.
  • Manuscripts that deal with transcultural adaptation and validation of instruments of measurements.
  • Manuscripts that translate a text published in another language and validate it on local patients.
  • Manuscripts that use questionnaires translated from the language of another country and their validation in local patients.
  • Manuscripts that present only in silico.
  • Manuscripts from the area of veterinary medicine.
  • Manuscripts that report toxicological studies.
  • Manuscripts containing purely descriptive observations will not be published.
  • Manuscripts reporting new techniques will be published only when adequately validated and judged by the Editors to represent a significant advance.
  • miRNA-based studies will receive low priority from the Journal except when the Editors consider the research provides an outstanding contribution to current literature.
 

 

Organization of the Manuscript

 

Most articles published in the Brazilian Journal of Medical and Biological Research will be organized into the following sections:

  • Title, Authors, Affiliations, Author for Correspondence and address
  • Abstract, Key words, Running Title
  • Introduction
  • Results
  • Material and Methods
  • Discussion
  • References
  • Acknowledgments
  • Tables with a short descriptive title and footnote legends
  • Figures with a short descriptive title, descriptive legends and uniformity in format

Continuous page numbers are required for all pages including figures. There are no specific length restrictions for the overall manuscript or individual sections. However, we urge authors to present and discuss their findings concisely. We recognize that some articles will not be best presented in our research article format. If you have a manuscript that would benefit from a different format, please contact the editors to discuss this further.
Our online submission system can support a large range of formats for text and graphics, but if you experience difficulties with the site or are concerned about the suitability of your files, please contact the Production Department of the Brazilian Journal of Medical and Biological Research (bjournal@terra.com.br).

Title Page 

Title – The title should be as short and informative as possible, should not contain non-standard acronyms or abbreviations, and should not exceed two printed lines.

Example:
Single-step purification of crotapotin and crotactine from Crotalus durissus terrificus venom using preparative isoelectric focusing

Please also provide a brief “running title” of up to 60 characters and spaces.

Example: 
Purification of crotapotin and crotactine

Authors and Affiliations 

Initials and last name(s) of author(s) (matched with superscript numbers identifying institutions). Institution(s) (Department, Faculty, University, City, State, Country) of each author (in Portuguese if authors are from Brazil).

Example: 
A.S. Aguiar1, A.R. Melgarejo1, C.R. Alves2 and S. Giovanni-De-Simone2,3

1Divisão de Animais Peçonhentos, Instituto Vital Brazil, Niterói, RJ, Brasil
2Laboratório de Microsequenciamento de Proteínas, Departamento de Bioquímica e Biologia Molecular, Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro, RJ, Brasil
3Departamento de Biologia Celular e Molecular, Universidade Federal Fluminense, Niterói, RJ, Brasil

One of the authors should be designated as the corresponding author. It is the corresponding author’s responsibility to ensure that the author list is accurate and complete. If the article has been submitted on behalf of a consortium, all consortium members and affiliations should be listed after the Acknowledgments.

Corresponding author: Name, complete mailing address, including zip code, telephone number, Fax number and E-mail of author to whom correspondence should be sent.

Key Words 

A list of key words or indexing terms (no more than 6) should be included. A capital letter should be used for the first letter of each key word, separated by a semicolon. The Journal recommends the use of medical subject headings of Index Medicus for key words to avoid the use of several synonyms as entry terms in the index for different papers on the same subject. Remember, key words are used by the Scielo Database (see http://www.scielo.br/bjmbr;articles search/subject) to index published articles.

Running title 

This short title, to be used as a page heading, should not exceed 60 letters and spaces.

Abstract 

Since abstracts are published separately by Information Services, they should contain sufficient hard data, to be appreciated by the reader. The Brazilian Journal publishes unstructured abstracts in a single paragraph. The abstract should not exceed 250 words.

The abstract should briefly and clearly present the objective, experimental approach, new results as quantitative data if possible, and conclusions. It should mention the techniques used without going into methodological detail and mention the most important results.

Abbreviations should be kept to a minimum and should be defined in both the Abstract and text.

Please do not include any reference citations in the abstract. If the use of a reference is unavoidable, the full citation should be given within the abstract.

Introduction 

The Introduction should put the focus of the manuscript into a broader context. As you compose the introduction, think of readers who are not experts in this field. This should state the purpose of the investigation and justification for undertaking the research and relationship to other work in the field. An extensive listing or review of the literature should not be used. If there are relevant controversies or disagreements in the field, they should be mentioned so that a non-expert reader can delve into these issues further. The Introduction should conclude with a brief statement of the overall aim of the experiments and a comment about what was achieved.

Material and Methods 

Sufficient information should be provided in the text or by referring to papers in generally available journals to permit the work to be repeated.
This section should provide enough detail for reproduction of the findings. Protocols for new methods should be included, but well-established protocols may simply be referenced. We encourage authors to submit, as separate files, detailed protocols for newer or less well-established methods. These will be linked to the article and will be fully accessable.

Results 

The results should be presented clearly and concisely. Tables and figures should be used only when necessary for effective comprehension of the data. The Results section should provide results of all of the experiments that are required to support the conclusions of the paper. There is no specific word limit for this section, but a description of experiments that are peripheral to the main message of the article and that detract from the focus of the article should not be included. The section may be divided into subsections, each with a concise subheading. Large datasets, including raw data, should be submitted as supplementary files; these are published online linked to the article. The Results section should be written in past tense. In some situations, it may be desirable to combine Results and Discussion into a single section.

Discussion 

The purpose of the Discussion is to identify new and relevant results and relate them to existing knowledge. Information given elsewhere in the text, especially in Results, may be cited but all of the results should not be repeated in detail in the Discussion. The Discussion should spell out the major conclusions and interpretations of the work including some explanation of the significance of these conclusions. How do the conclusions affect the existing assumptions and models in the field? How can future research build on these observations? What are the key experiments that must be done? The Discussion should be concise and tightly argued. If warranted, the Results and Discussion may be combined into one section.

Acknowledgments 

When appropriate, briefly acknowledge technical assistance, advice and contributions from colleagues. People who contributed to the work, but do not fit the criteria for authors should be listed in the Acknowledgments, along with their contributions. Donations of animals, cells, or reagents should also be acknowledged You must also ensure that anyone named in the Acknowledgments agrees to being so named. Financial support for the research and fellowships should be acknowledged in this section (agency and grant number).

Figures 

Figures must be submitted in high-resolution version (900 dpi). Please ensure that the files conform to our Guidelines for Figure Preparation when preparing your figures for production.

If the manuscript has blots, the authors must submit the original uncropped blots as supplementary material. These uncropped blots must contain the film annotations and the ladder indicating the protein molecular weight.

Remember to identify the blots, the bands, and the figure to which they correspond.

Preparing figure files for submission 

The Brazilian Journal of Medical and Biological Research encourages authors to use figures where this will increase the clarity of an article. The use of color figures in articles is free of charge. The following guidelines must be observed when preparing figures. Failure to do so is likely to delay acceptance and publication of the article.

  • Each figure of a manuscript should be submitted as a single file in jpg format with 900 dpi.
  • Figures should be numbered in the order they are first mentioned in the text, and uploaded in this order.
  • Figure titles and legends should be provided in the main manuscript, not in the graphic file.
  • The aim of the figure legend should be to describe the key messages of the figure, but the figure should also be discussed in the text.
  • An enlarged version of the figure and its full legend will often be viewed in a separate window online, and it should be possible for a reader to understand the figure without moving back and forth between this window and the relevant parts of the text.
  • Each legend should have a concise title of no more than 15 words. The legend itself should be succinct, while still explaining all symbols and abbreviations. Avoid lengthy descriptions of methods. Statistical information should be given as well as the statistical tests used.
  • Arrows or letters should be used in the figure and explained in the legend to identify important structures.
  • Figures with multiple panels should use capital letters A, B, C, etc. to identify the panels.
  • Each figure should be closely cropped to minimize the amount of white space surrounding the illustration. Cropping figures improves accuracy when placing the figure in combination with other elements, when the accepted manuscript is prepared for publication. For more information on individual figure file formats, see Guidelines for figures.
  • Individual figure files should not exceed 5 MB. If a suitable format is chosen, this file size is adequate for extremely high quality figures.
  • Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures (or tables) that have previously been published elsewhere. In order for all figures to be open-access, authors must have permission from the rights holder if they wish to include images that have been published elsewhere in non-open-access journals. Permission should be indicated in the figure legend, and the original source included in the reference list.

Supported file types

The following file formats can be accepted.

  • JPG – with 900 dpi.

Micrographs should be treated like photographs with the following additional guidelines

  • Electron micrographs must contain a magnification bar with its equivalence in micrometers. This information can be found on all micrographs together with the magnification size.
  • Details of any stains used and the method of preparation the sample should be given in the figure legend or in the Methods section.
  • Detailed information about the microscope used should be included in the Methods section.
  • The type of camera, photographic software and details of any subsequent image manipulation should be included in the Methods section.

More information see Guidelines for figures.

Tables 

  • Tables must be submitted in Word (.doc) or Excel (.xls), not as an image.
  • Tables must be numbered consecutively with Arabic numerals in the text.
  • Tables must have a concise and descriptive title.
  • All explanatory information should be given in a footnote below the table. Footnotes should be used to explain abbreviations and provide statistical information, including statistical tests used.
  • All abbreviations must be defined in this footnote, even if they are explained in the text.
  • Tables must be understandable without referring to the text.
  • Tables occupying more than one printed page should be avoided, if possible.
  • Vertical and diagonal lines should not be used in tables; instead, indentation and vertical or horizontal space should be used to group data.
  • Tables in Excel must be cell-based; do not use picture elements, text boxes, tabs, or returns in tables.

References 

Only published or accepted manuscripts should be included in the reference list. Meeting abstracts, conference talks, or papers that have been submitted but not yet accepted should not be cited. Limited citation of unpublished work should be included in the body of the text only. All personal communications should be supported by a letter from the relevant authors. Authors are responsible for the accuracy and completeness of their references and for correct text citation. When possible, references which are easily available in English should be cited.

The BJMBR uses the numbered citation (citation-sequence) method. References are listed and numbered in the order that they appear in the text. In the text, citations should be indicated by the reference number in parentheses. Multiple citations within a single set of parentheses should be separated by commas without a space (1,5,7). Where there are more than three sequential citations, they should be given as a range (4-9).

Because all references will be linked electronically (doi), if possible, to the papers they cite, proper formatting of the references is crucial. For all references, list the first 6 authors followed by et al., Title, Journal (abbreviation), Year, Volume, Complete Pages.

The Brazilian Journal of Medical and Biological Research follows the reference format of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, which can be found on the website of the National Library of Medicine.

Please use the following style for the reference list:

Published Papers. First 6 authors followed by et al., Title, Journal (abbreviation in italics), Year, Volume, Complete Pages.

Lammers AE, Hislop AA, Flynn Y, Haworth SG. The 6-minute walk test: normal values for children of 4-11 years of age. Arch Dis Child 2008; 93: 464-468.

Zhang Q, Malik P, Pandey D, Gupta S, Jagnandan D, Belin de CE, et al. Paradoxical activation of endothelial nitric oxide synthase by NADPH oxidase. Arterioscler Thromb Vasc Biol 2008; 28: 1627-1633.

Article accepted for publication but not yet published. First 6 authors followed by et al., Title, Journal (abbreviation), Year of expected publication, (in press) at the end of the citation.

Janiszewski M, Lopes LR, Carmo AO, Pedro MA, Brandes RP, Santos CXC, et al. Regulation of NAD(P)H oxidase by associated protein disulfide isomerase in vascular smooth muscle cells. J Biol Chem 2005 (in press).

Internet Communication. Ensure that URLs are active and available.

Brasil. Associação Brasileira para o Estudo da Obesidade: pesquisa da população brasileira. http://www.abeso.org.br. Accessed February 22, 2008.

Information behaviour of the researcher of the future, CIBER Report. http://www.bl.uk/news/2008/pressrelease20080116.html.

CAPES Statistics. http://www.capes.gov.br/capes/portal. Accessed March 16, 2006.

CNPq Plataforma Lattes, “Investimentos do CNPq em CT&I”. http://fomentonacional.cnpq.br/dmfomento/home/index.jsp. Accessed March 16, 2006.

Audiovisual Material

Physician’s Desk Reference (PDR). Release 2003.1AX. [CD-ROM]. Montvale: Thomson PDR; 2003.

Computer Program

Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, et al. Epi info, version 6.04: a word processing database and statistics program for public health on IBM-compatible microcomputers. [Computer program]. Atlanta: Centers of Disease Control and Prevention; 1998.

Statistical Package for the Social Sciences (SPSS). Version 12.0. [Computer program]. Chicago: SPSS Inc.; 2006.

Patent

Larsen CE, Trip R, Johnson CR. Methods for procedures related to the electrophysiology of the heart. Patent No. 5.529.067. Novoste Corporation; 1995.

Book, Whole. Authors, Book title, Edition, City, Publisher, Year.

American College of Sports Medicine. Diretrizes do ACSM para os testes de esforço e sua prescrição. Rio de Janeiro: Guanabara Koogan; 2007.

Book, Chapter. Authors, Chapter Title, Editors, Book title, Edition, City, Publisher, Year, Pages of citation.

Kronfol A. Behavioral effects of cytokines: a psychiatrist’s perspective. In: Plotnikoff NP, Faith RE, Murgo AJ, Good RA (Editors), Cytokines, stress and immunity. London: CRC Press; 2007. p 1-16.

Kintzios SE. What do we know about cancer and its therapy? In: Kintzios SE, Barberaki MG (Editors), Plants that fight cancer. New York: CRC Press; 2004. p 1-14.

Report

WHO (World Health Organization), IPCS (International Program in Chemical Safety). Environmental health criteria: 118 Inorganic mercury. Geneva: World Health Organization; 1991.

National Commission on Sleep Disorders Research. Wake up America: a national sleep alert. Washington: Government Printing Office; 1993.

National Heart Lung and Blood Institute. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention: NHLBI/WHO Workshop Report. Bethesda: National Institute of Health. National Heart, Lung and Blood Institute publication No. 02-3659; 2006.

Thesis

Joselevitch C. Visão no ultravioleta em Carassius auratus (Ostariophysi, Cypriformes, Cyprinidae): estudo eletrofisiológico do sistema cone – células horizontais. [Master’s thesis]. São Paulo: Instituto de Psicologia, USP; 1999.

Conference, Symposium Proceedings. Cite papers only from published proceedings.

Hejzlar RM, Diogo PA. The use of water quality modelling for optimising operation of a drinking water reservoir. Proceedings of the International Conference Fluid Mechanics and Hydrology. 1999 Jun 23-26; Prague. Prague: Institute of Hydrodynamics AS CR; 1999. p 475-482.

Unpublished results”, “Personal communication” and “Submitted papers”. Reference should appear in the text with the individual name(s) and initials and not in the reference list.

(Santos CS, da-Silva GB, Martins LT, unpublished results).

It is assumed that the author has obtained permission from the source when “personal communication” is cited.

 

 

How to submit a manuscript to the BJMBR

 

Author Instructions
Please make sure you have read through these instructions carefully before beginning the submission process.
Please go to www.bjournal.com.br at the right-hand corner of the home page and click on SUBMIT A MANUSCRIPT and follow the directions. If you need further assistance, please contact the Journal Staff directly (bjournal@terra.com.br). Manuscript preparation instructions can be found at http://www.bjournal.com.br.

Submission Process
The seven steps of the submission process are: Type, Title & Abstract; Attributes; Authors & Institutions; Recommended Reviewers; Details & Comments; File upload; Review & Submit.
The steps each contain sub-steps that can be accessed by clicking on their respective tabs.

 

 

Manuscript criteria and information

 

The Brazilian Journal of Medical and Biological Research is a peer-reviewed electronic journal published monthly by the Associação Brasileira de Divulgação Científica (ABDC).

Submission of a manuscript to the Brazilian Journal implies that the data have not been published previously and will not be submitted for publication elsewhere while the manuscript is under review.

The following represent "prior publication": any printed material in excess of 500 words describing results or methods of a submitted/in press manuscript; published tables or illustrations that duplicate the content of a manuscript; electronic manuscripts or posters available via the Internet. When part of the material in a manuscript has been presented as a preliminary communication or in an unrefereed symposium, this should be cited as a footnote on the title page and a copy should accompany the submitted manuscript.

 

 

Copyright

 

The Brazilian Journal of Medical and Biological Research (BJMBR) applies the Creative Commons Attribution License (CCAL) to all works published (read the human-readable summary or the full license legal code). Under the CCAL, authors retain ownership of the copyright for their article and can allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles published in the BJMBR, as long as the original authors and source are cited. No permission is required from the publishers.

 

 

Cell biology

 

The main characteristic of research papers in the area of Cell Biology is the emphasis on the integration at the cellular level of biochemical, molecular, genetic, physiological, and pathological information. This section considers manuscripts dealing with either prokaryotic or eukaryotic biological systems at any developmental stage. Papers on all aspects of cellular structure and function are considered to be within the scope of Cell Biology by the BJMBR. The Editors encourage submission of manuscripts defining cell biology as an area of convergence of several other research fields, especially manuscripts providing insights into the cellular basis of immunology, neurobiology, microbial pathology, developmental biology, and disease. Manuscripts containing purely descriptive observations will not be published. Manuscripts reporting new techniques will be published only when adequately validated and judged by the Editors to represent a significant advance.

 

 

Biological activity of natural products

 

The Journal will consider papers for publication which describe the activity of substances of biological origin only if they satisfy all of the following criteria:

  • Papers should describe the separation of the crude material into fractions (not necessarily into homogeneous materials) with the fractions containing biological activity identified clearly in the separation scheme. Phytochemical studies should be accompanied by biological tests. A survey of pharmacological activity of plant extracts or teas will not be considered for publication.
  • In addition to the demonstration of activity in one or more biological system, experiments must be performed attempting to provide information concerning the mechanism(s) of action of the substance(s) being tested.
  • Sufficient experimental information must be provided to permit repetition of the preparation of fractions and the bioassay used.
  • Sources should be identified completely, and, if plant material, a specimen should be classified by an expert and deposited in a local botanical garden, university or research institute. The name and institution of the person who classified the plant and the number of the voucher under which it was deposited should be provided in the Material and Methods section.
  • The Journal does not publish toxicological studies.
 

 

Editorial review and processing

 

The receipt of manuscripts is acknowledged immediately. Once a paper has been evaluated by peer review, the authors will be notified of the editorial decision.

Papers accepted on scientific merit for publication sent to authors for scientific english correction and galley proofs will be sent to authors for the correction of errors. Authors are responsible for all statements made in their article, including changes made by the copy editor and authorized by the corresponding author.

The dates of receipt and acceptance will be published for each article. Authors are expected to return manuscripts to the Journal within 15 calendar days after they are sent to them for modifications or for style and copy editing, and to return galley proofs within 72 hours. The total number of "late" days will be added to the submission date at the time of publication.

 

 

Related links

 

 

Associação Brasileira de Divulgação Científica Av. Bandeirantes, 3900, 14049-900 Ribeirão Preto SP Brazil, Tel. / Fax: +55 16 3315-9120 - Ribeirão Preto - SP - Brazil
E-mail: bjournal@terra.com.br